Women Can Wait Years for an Endometriosis Diagnosis. New Tech Could Change That

Women can wait years for an endometriosis – Endometriosis, a condition that affects approximately one in ten women in the UK, often leads to prolonged suffering before a clear diagnosis is reached. For many, the journey to understanding their symptoms involves years of uncertainty, repeated consultations, and a range of diagnostic procedures. A recent breakthrough in imaging technology, tested in a pilot study at Oxford University, may offer a solution by enabling earlier detection of the disease. This innovation could significantly reduce the time it takes for women to receive a diagnosis, according to the research team.

Traditional Scans Miss Early Signs

Conventional methods such as ultrasounds and MRIs typically rely on visual identification of tissue changes. However, these tools often fail to detect the earliest stages of endometriosis, which can be particularly challenging to diagnose. Dr. Tatjana Gibbons, the lead researcher of the study, explains that standard scans mainly reveal signs of advanced disease, leaving many patients with ambiguous results. “This leads to frustration, as individuals may experience severe symptoms even when their scans appear normal,” she notes.

“Many struggle with symptoms, despite being told they have normal imaging results.”

The new technique, developed by Oxford researchers, combines specialised CT scans with a molecular tracer called maraciclatide. This tracer is designed to bind to areas where new blood vessels are forming—a critical indicator of early endometriosis progression. By highlighting these subtle changes, the method offers a more precise way to identify the condition before it becomes widespread.

During the pilot study, 19 participants with confirmed or suspected endometriosis underwent the SPECT-CT scan after receiving the molecular tracer. The results were promising: the technique successfully detected the presence or absence of the disease in 16 of the women and identified 14 out of 17 cases that were later verified through surgery. Dr. Gibbons describes the findings as “exciting,” emphasizing that this approach could serve as a reliable tool for diagnosing the most common and difficult-to-spot form of the condition: superficial peritoneal endometriosis.

A Personal Story of Delayed Diagnosis

For Gabriella Pearson, a 33-year-old co-founder of the Menstrual Health Project charity, the process of uncovering her endometriosis diagnosis was a long and arduous one. She began experiencing debilitating menstrual pain at the age of 10, which persisted for over a decade and progressively worsened. Throughout this time, she consulted numerous doctors, who often dismissed her symptoms as routine or attributed them to stress or irritable bowel syndrome.

“If I had been listened to and diagnosed earlier, I would have been in a very different position now.”

It wasn’t until she visited a GP after six years of fluctuating health that she received a tentative diagnosis. The condition had already begun to impact her organs, including her bowel, bladder, and ovary, causing lasting damage. Pearson recalls the physical and emotional toll of the disease: “The pain and complications prevented me from advancing in my career and pursuing university.” She also highlights the broader consequences, such as mental health struggles, financial strain, and challenges with fertility.

Currently, the only definitive way to confirm endometriosis is through a laparoscopy—a minimally invasive procedure that involves inserting a small camera into the abdomen. While this method is effective, it often takes months or even years to schedule, adding to the delays in treatment. Pearson, who endured a painful ultrasound during her initial investigations, stresses the need for non-invasive alternatives. “I really struggled with an invasive ultrasound, which was very painful,” she says. “We deserve something more consistent and reliable for patients.”

Expert Perspectives on the Breakthrough

Dr. Lucy Whitaker, a gynaecologist and researcher at the University of Edinburgh, underscores the importance of this development. Although not directly involved in the study, she calls for urgent advancements in non-invasive imaging techniques. “There’s a desperate need for new tools that can catch the disease earlier,” she states. “This preliminary data is really exciting—it gives us a real opportunity to intervene sooner and provide timely treatment.”

Early diagnosis is crucial for managing endometriosis effectively. The condition can cause severe pain, infertility, and chronic fatigue, often mimicking symptoms of other ailments like fibromyalgia or pelvic inflammatory disease. Without a clear diagnosis, patients may endure years of unexplained discomfort, leading to significant disruptions in their personal and professional lives. The new scanning method addresses this gap by focusing on molecular markers rather than relying solely on structural imaging.

Dr. Gibbons highlights that the technique’s ability to detect vascular changes—a key feature of endometriosis in its early stages—could revolutionise the diagnostic process. “If this method proves effective in larger studies, it could offer a transformative approach to identifying the disease,” she explains. The research team is now working to validate the findings through expanded trials, aiming to establish its reliability across diverse patient groups.

Endometriosis is a complex disorder that can develop in various parts of the body, including the pelvic cavity, abdomen, and even the brain. Its progression is often slow, making early intervention difficult. The new technology, however, provides a potential pathway to spot the disease before it becomes more severe. By detecting subtle indicators, it may allow for treatments that can alleviate symptoms and improve long-term quality of life.

What’s Next for the Technology?

While the pilot study demonstrates the technique’s potential, further research is necessary to confirm its effectiveness on a larger scale. Scientists are optimistic about its ability to reduce diagnostic delays and provide clearer answers for patients. The method could also aid in monitoring the disease’s progression over time, helping healthcare providers tailor treatments to individual needs.

For Pearson, the prospect of earlier diagnosis is transformative. “If people are identified sooner, they could avoid the long-term complications that I’ve faced,” she says. She believes that this innovation would not only ease the burden on patients but also empower them to make informed decisions about their health and future. The impact of endometriosis extends beyond physical pain, affecting mental well-being and life opportunities. A faster, more accurate diagnostic tool could help mitigate these effects, offering hope for millions of women worldwide.

As the research moves forward, the focus will be on refining the technique and ensuring its accessibility. If successful, this method could become a standard part of endometriosis screening, reducing the average nine-year wait for a diagnosis. It also represents a step toward more patient-centred care, where symptoms are taken seriously and treated with precision. With further validation, the technology may soon be available to diagnose endometriosis in its earliest stages, giving women a chance to reclaim their health and lives sooner than ever before.